Payment overview · 2025
General Payments
$275.26
3 reported records · 2 companies
Healthcare provider profile · identity verified
James M Caruso, MD
Allopathic & Osteopathic Physicians|Family Medicine · CHICAGO, IL · NPI 1275524449
Verified facts
What the public records show
CMS Open Payments records show James M Caruso, MD received $275.26 in general payments during 2025 across 3 reported records.
Alphatec Spine, Inc accounted for 89.8% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Alphatec Spine, Inc | Unresolved — no canonical attribution shown | $247.05 | 89.8% | 1 | 2025 |
| Fisher & Paykel Healthcare Inc | Unresolved — no canonical attribution shown | $28.21 | 10.2% | 2 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $275.26 | 3 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| FISHER & PAYKEL HEALTHCARE Normalized: fisher paykel healthcare |
Device | Fisher & Paykel Healthcare Inc | $28.21 | 2 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
None of this doctor’s payer companies has same-entity product evidence that passes the publication threshold. The site does not infer company ownership, affiliates, or generic manufacturers.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 337 | 84 |
| Hydralazine Hcl | Hydralazine Hcl | 294 | 73 |
| Amlodipine Besylate | Amlodipine Besylate | 276 | 82 |
| Furosemide | Furosemide | 275 | 79 |
| Gabapentin | Gabapentin | 261 | 61 |
| Losartan Potassium | Losartan Potassium | 256 | 73 |
| Levothyroxine Sodium | Levothyroxine Sodium | 255 | 63 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 241 | 72 |
| Omeprazole | Omeprazole | 223 | 65 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 200 | 46 |
| Potassium Chloride | Potassium Chloride | 191 | 53 |
| Carvedilol | Carvedilol | 184 | 41 |
| Eliquis | Apixaban | 176 | 50 |
| Diclofenac Sodium | Diclofenac Sodium | 169 | 40 |
| Alendronate Sodium | Alendronate Sodium | 166 | 31 |
| Metoprolol Succinate | Metoprolol Succinate | 161 | 41 |
| Trulicity | Dulaglutide | 160 | 23 |
| Metformin Hcl | Metformin Hcl | 156 | 41 |
| Tamsulosin Hcl | Tamsulosin Hcl | 154 | 42 |
| Breo Ellipta | Fluticasone/Vilanterol | 144 | 26 |
| Pantoprazole Sodium | Pantoprazole Sodium | 139 | 33 |
| Lisinopril | Lisinopril | 137 | 36 |
| Celecoxib | Celecoxib | 135 | 35 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 132 | 68 |
| Montelukast Sodium | Montelukast Sodium | 130 | 40 |
| Nifedipine Er | Nifedipine | 128 | 25 |
| Fluticasone Propionate | Fluticasone Propionate | 126 | 22 |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 124 | 32 |
| Clonidine Hcl | Clonidine Hcl | 122 | 23 |
| Metoprolol Tartrate | Metoprolol Tartrate | 110 | 25 |
| Ezetimibe | Ezetimibe | 108 | 18 |
| Ibuprofen | Ibuprofen | 105 | 20 |
| Mirtazapine | Mirtazapine | 102 | 34 |
| Azithromycin | Azithromycin | 99 | 55 |
| Escitalopram Oxalate | Escitalopram Oxalate | 99 | 24 |
| Farxiga | Dapagliflozin Propanediol | 94 | 20 |
| Trazodone Hcl | Trazodone Hcl | 93 | 24 |
| Famotidine | Famotidine | 90 | 17 |
| Allopurinol | Allopurinol | 84 | 15 |
| Januvia | Sitagliptin Phosphate | 84 | 15 |
| Jardiance | Empagliflozin | 77 | 23 |
| Ventolin Hfa | Albuterol Sulfate | 76 | 16 |
| Chlorthalidone | Chlorthalidone | 75 | 12 |
| Clopidogrel | Clopidogrel Bisulfate | 75 | 18 |
| Levetiracetam | Levetiracetam | 75 | 14 |
| Vascepa | Icosapent Ethyl | 72 | 17 |
| Meclizine Hcl | Meclizine Hcl | 66 | 23 |
| Metoclopramide Hcl | Metoclopramide Hcl | 65 | 12 |
| Quetiapine Fumarate | Quetiapine Fumarate | 64 | 15 |
| Memantine Hcl | Memantine Hcl | 63 | 18 |
| Hydrochlorothiazide | Hydrochlorothiazide | 62 | 20 |
| Invokana | Canagliflozin | 62 | suppressed |
| Alcohol Prep Pads | Alcohol Antiseptic Pads | 60 | 13 |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 59 | 14 |
| Duloxetine Hcl | Duloxetine Hcl | 59 | 14 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 59 | suppressed |
| Spironolactone | Spironolactone | 59 | 17 |
| Buspirone Hcl | Buspirone Hcl | 57 | 21 |
| Methylprednisolone | Methylprednisolone | 54 | 36 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 53 | 19 |
| Dutasteride | Dutasteride | 53 | 11 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 51 | 30 |
| Alcohol Pads | Alcohol Antiseptic Pads | 50 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 50 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 49 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 48 | suppressed |
| Glipizide | Glipizide | 47 | 12 |
| Myrbetriq | Mirabegron | 46 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 46 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 45 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 43 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 42 | 17 |
| Megestrol Acetate | Megestrol Acetate | 39 | suppressed |
| Donepezil Hcl | Donepezil Hcl | 38 | suppressed |
| Janumet | Sitagliptin Phos/Metformin Hcl | 38 | suppressed |
| Ozempic | Semaglutide | 38 | 12 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 37 | 29 |
| Ammonium Lactate | Ammonium Lactate | 36 | suppressed |
| Sertraline Hcl | Sertraline Hcl | 36 | 15 |
| Glimepiride | Glimepiride | 35 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 35 | 22 |
| Torsemide | Torsemide | 35 | suppressed |
| Sucralfate | Sucralfate | 34 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 33 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 33 | 14 |
| Humalog Mix 75-25 | Insulin Lispro Protamin/Lispro | 31 | suppressed |
| Linzess | Linaclotide | 31 | 11 |
| Xarelto | Rivaroxaban | 31 | 11 |
| Glipizide Er | Glipizide | 29 | suppressed |
| Colchicine | Colchicine | 27 | suppressed |
| Pro Comfort Alcohol Pads | Alcohol Antiseptic Pads | 27 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 26 | suppressed |
| Naproxen | Naproxen | 26 | suppressed |
| Valsartan | Valsartan | 26 | suppressed |
| Hydrocortisone | Hydrocortisone | 25 | suppressed |
| Risperidone | Risperidone | 24 | suppressed |
| Simvastatin | Simvastatin | 24 | suppressed |
| Finasteride | Finasteride | 23 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 23 | 13 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 23 | suppressed |
| Advair Hfa | Fluticasone Propion/Salmeterol | 22 | suppressed |
| Levofloxacin | Levofloxacin | 22 | 17 |
| Midodrine Hcl | Midodrine Hcl | 22 | suppressed |
| Spiriva Handihaler | Tiotropium Bromide | 22 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 22 | suppressed |
| Galantamine Hbr | Galantamine Hbr | 21 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 20 | suppressed |
| Entresto | Sacubitril/Valsartan | 20 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 20 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 20 | suppressed |
| Amoxicillin | Amoxicillin | 19 | 14 |
| Niacin Er | Niacin | 19 | suppressed |
| Oxcarbazepine | Oxcarbazepine | 19 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 19 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 18 | suppressed |
| Baclofen | Baclofen | 18 | suppressed |
| Dulera | Mometasone/Formoterol | 18 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 18 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 17 | suppressed |
| Ketoconazole | Ketoconazole | 17 | suppressed |
| Lansoprazole | Lansoprazole | 17 | suppressed |
| Pravastatin Sodium | Pravastatin Sodium | 17 | suppressed |
| Restasis | Cyclosporine | 17 | suppressed |
| Betamethasone Dipropionate | Betamethasone Dipropionate | 16 | suppressed |
| Fluocinonide | Fluocinonide | 16 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 16 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 16 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 15 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 15 | suppressed |
| Novolog Mix 70-30 | Insulin Aspart Prot/Insuln Asp | 15 | suppressed |
| Ondansetron Odt | Ondansetron | 15 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 14 | suppressed |
| Bupropion Xl | Bupropion Hcl | 14 | suppressed |
| Cyclosporine | Cyclosporine | 14 | suppressed |
| Dexlansoprazole Dr | Dexlansoprazole | 14 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 14 | suppressed |
| Easy Comfort Pen Needle | Pen Needle, Diabetic | 14 | suppressed |
| Gemfibrozil | Gemfibrozil | 14 | suppressed |
| Novolin 70-30 | Insulin Nph Hum/Reg Insulin Hm | 14 | suppressed |
| Nystop | Nystatin | 14 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 14 | suppressed |
| Primidone | Primidone | 14 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 14 | suppressed |
| Cefdinir | Cefdinir | 13 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 13 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 13 | suppressed |
| Fiasp Flextouch | Insulin Aspart (Niacinamide) | 13 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 13 | suppressed |
| Irbesartan | Irbesartan | 13 | suppressed |
| Prednisone | Prednisone | 13 | suppressed |
| Symtuza | Darunavir/Cob/Emtri/Tenof Alaf | 13 | suppressed |
| Amantadine | Amantadine Hcl | 12 | suppressed |
| Bethanechol Chloride | Bethanechol Chloride | 12 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 12 | suppressed |
| Easy Comfort Pen Needles | Pen Needle, Diabetic | 12 | suppressed |
| Humalog Mix 75-25 Kwikpen | Insulin Lispro Protamin/Lispro | 12 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 12 | suppressed |
| Klor-Con M20 | Potassium Chloride | 12 | suppressed |
| Lurasidone Hcl | Lurasidone Hcl | 12 | suppressed |
| Tradjenta | Linagliptin | 12 | suppressed |
| Biktarvy | Bictegrav/Emtricit/Tenofov Ala | 11 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 11 | 11 |
| Cephalexin | Cephalexin | 11 | suppressed |
| Fenofibrate | Fenofibrate | 11 | suppressed |
| Fesoterodine Fumarate Er | Fesoterodine Fumarate | 11 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 11 | suppressed |
| Nystatin | Nystatin | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $275.26 · 3 records | Alphatec Spine, Inc | FISHER & PAYKEL HEALTHCARE | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error